MALVERN, Pa., June 24, 2014 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) (the “Company” ) announced the closing of its previously-announced offering of $47 million aggregate principal amount of its 8% Convertible Senior Notes due 2019 (the “Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”).
Help employers find you! Check out all the jobs and post your resume.
